Found: 20
Select item for more details and to access through your institution.
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Multiple Myeloma Based on Bone Marrow Homing.
- Published in:
- Advanced Materials, 2022, v. 34, n. 46, p. 1, doi. 10.1002/adma.202107883
- By:
- Publication type:
- Article
Estrogen‐Responsive Gene MAST4 Regulates Myeloma Bone Disease.
- Published in:
- Journal of Bone & Mineral Research, 2022, v. 37, n. 4, p. 711, doi. 10.1002/jbmr.4507
- By:
- Publication type:
- Article
ALCAM regulates multiple myeloma chemoresistant side population.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 2, p. 1, doi. 10.1038/s41419-022-04556-8
- By:
- Publication type:
- Article
Minimal residual disease in multiple myeloma: current status.
- Published in:
- Biomarker Research, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40364-021-00328-2
- By:
- Publication type:
- Article
Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.694331
- By:
- Publication type:
- Article
BMI1 regulates multiple myeloma-associated macrophage’s pro-myeloma functions.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 5, p. 1, doi. 10.1038/s41419-021-03748-y
- By:
- Publication type:
- Article
High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 1, p. 33, doi. 10.1007/s00432-020-03373-w
- By:
- Publication type:
- Article
PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 6897, doi. 10.2147/OTT.S245578
- By:
- Publication type:
- Article
Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
- Published in:
- Stem Cell Research & Therapy, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13287-019-1502-8
- By:
- Publication type:
- Article
SLC2A5 overexpression in childhood philadelphia chromosome‐positive acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 2, p. 242, doi. 10.1111/bjh.15580
- By:
- Publication type:
- Article
Antiproliferative and Apoptosis Triggering Potential of Paclitaxel-Based Targeted-Lipid Nanoparticles with Enhanced Cellular Internalization by Transferrin Receptors—a Study in Leukemia Cells.
- Published in:
- Nanoscale Research Letters, 2018, v. 13, n. 1, p. 1, doi. 10.1186/s11671-018-2688-x
- By:
- Publication type:
- Article
Targeting of HER3 with Functional Cooperative miRNAs Enhances Therapeutic Activity in HER2-Overexpressing Breast Cancer Cells.
- Published in:
- Biological Procedures Online, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s12575-018-0081-x
- By:
- Publication type:
- Article
Epigenetic mechanism of survivin dysregulation in human cancer.
- Published in:
- SCIENCE CHINA Life Sciences, 2018, v. 61, n. 7, p. 808, doi. 10.1007/s11427-017-9230-2
- By:
- Publication type:
- Article
Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34<sup>+</sup> cells.
- Published in:
- Stem Cell Research & Therapy, 2018, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13287-018-0902-5
- By:
- Publication type:
- Article
Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0356-0
- By:
- Publication type:
- Article
Targeting of erbB3 receptor to overcome resistance in cancer treatment.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-105
- By:
- Publication type:
- Article
Role of erbB3 receptors in cancer therapeutic resistance.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2014, v. 46, n. 3, p. 190, doi. 10.1093/abbs/gmt150
- By:
- Publication type:
- Article
The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-134
- By:
- Publication type:
- Article
Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.
- Published in:
- Breast Cancer Research, 2013, v. 15, n. 5, p. 2, doi. 10.1186/bcr3563
- By:
- Publication type:
- Article
Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article